UIM6:F:F-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 493.35

Change

+2.42 (+0.49)%

Market Cap

USD 0.69B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.25 (-0.91%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.06 (-0.11%)

USD 109.59B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.72 (+0.13%)

USD 96.22B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.44 (-0.78%)

USD 91.00B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.90 (-1.21%)

USD 54.70B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 52.21B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.44 (+0.45%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.13%)

USD 40.38B
0ZC:F Zscaler Inc

+2.10 (+1.37%)

USD 37.92B

ETFs Containing UIM6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.11% 84% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.11% 81% B- 66% D+
Trailing 12 Months  
Capital Gain 26.04% 81% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.04% 77% C+ 66% D+
Trailing 5 Years  
Capital Gain 89.30% 95% A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.30% 95% A 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.65% 89% A- 78% C+
Dividend Return 14.65% 87% B+ 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.05% 42% F 76% C+
Risk Adjusted Return 97.35% 95% A 95% A
Market Capitalization 0.69B 65% D 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.